Plain-English translation of NCT05382663 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Researchers are testing the Alio Remote Monitoring System, a wearable patch device designed to non-invasively monitor patients on dialysis for end-stage kidney disease. The device is worn over the blood vessel area used for dialysis, and its readings will be compared to standard blood tests to see if it accurately tracks important health information. This study aims to determine whether this wearable technology can help doctors monitor dialysis patients more easily.
Current monitoring methods for dialysis patients require frequent blood draws and lab work. This trial exists to see if a simple wearable patch could provide real-time health information without the need for repeated blood tests, potentially making dialysis care easier and less burdensome for patients.
You will be asked to wear the Alio monitoring patch during four of your regularly scheduled dialysis sessions. The patch stays on throughout your entire dialysis appointment. During the study, you'll have blood draws taken so researchers can compare the patch's measurements to your actual lab results, and your vital signs may be checked. The entire study involves your regular dialysis visits with this added monitoring component.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
Jordan
Sponsor
Alio, Inc.
Enrollment target
~75 participants
Started
March 2022
Primary completion
November 2024
Age range
18 Years and older
Last updated on clinicaltrials.gov in June 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Emilee Scates
Alkhansaa Hospital